Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20668005 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors
Conditions: Nasopharyngeal Carcinoma;   Hepatocellular Carcinoma;   Breast Carcinoma
Intervention: Biological: tumor infiltrating lymphocytes, IL-2
2 Recruiting Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin+TIL;   Drug: Cisplatin

Study has passed its completion date and status has not been verified in more than two years.